181 related articles for article (PubMed ID: 27010795)
1. Nano Spray Drying Technique as a Novel Approach To Formulate Stable Econazole Nitrate Nanosuspension Formulations for Ocular Use.
Maged A; Mahmoud AA; Ghorab MM
Mol Pharm; 2016 Sep; 13(9):2951-65. PubMed ID: 27010795
[TBL] [Abstract][Full Text] [Related]
2. Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins.
Abd El-Gawad AEH; Soliman OA; El-Dahan MS; Al-Zuhairy SAS
AAPS PharmSciTech; 2017 Jul; 18(5):1795-1809. PubMed ID: 27830515
[TBL] [Abstract][Full Text] [Related]
3. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
4. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
5. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
6. Techniques to develop and characterize nanosized formulation for salbutamol sulfate.
Bhavna ; Ahmad FJ; Khar RK; Sultana S; Bhatnagar A
J Mater Sci Mater Med; 2009 Dec; 20 Suppl 1():S71-6. PubMed ID: 18543087
[TBL] [Abstract][Full Text] [Related]
7. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
8. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
9. Preparation and solidification of redispersible nanosuspensions.
Zhang X; Guan J; Ni R; Li LC; Mao S
J Pharm Sci; 2014 Jul; 103(7):2166-2176. PubMed ID: 24840928
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.
Allam AN; Hamdallah SI; Abdallah OY
Int J Nanomedicine; 2017; 12():4733-4745. PubMed ID: 28740381
[TBL] [Abstract][Full Text] [Related]
11. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
13. Exploration of alginates as potential stabilizers of nanosuspension.
Guan J; Zhang Y; Liu Q; Zhang X; Chokshi R; Mao S
AAPS PharmSciTech; 2017 Nov; 18(8):3172-3181. PubMed ID: 28536795
[TBL] [Abstract][Full Text] [Related]
14. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
15. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
Kumar S; Xu X; Gokhale R; Burgess DJ
Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
[TBL] [Abstract][Full Text] [Related]
16. Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.
Niwa T; Miura S; Danjo K
Pharm Res; 2011 Sep; 28(9):2339-49. PubMed ID: 21626059
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate.
Passerini N; Gavini E; Albertini B; Rassu G; Di Sabatino M; Sanna V; Giunchedi P; Rodriguez L
J Pharm Pharmacol; 2009 May; 61(5):559-67. PubMed ID: 19405993
[TBL] [Abstract][Full Text] [Related]
18. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
19. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
Karakucuk A; Celebi N; Teksin ZS
Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
[TBL] [Abstract][Full Text] [Related]
20. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
Qiao F; Zhao Y; Mai Y; Guo J; Dong L; Zhang W; Yang J
Planta Med; 2020 May; 86(8):538-547. PubMed ID: 32294789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]